Literature DB >> 2453743

Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.

Y Hattori1, T Hidaka, K Aisaka, F Satoh, T Ishihara.   

Abstract

Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453743     DOI: 10.1097/00005344-198804000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Acute fatal poisoning with pilsicainide and atenolol.

Authors:  W Hikiji; K Kudo; N Nishida; T Ishida; Y Usumoto; A Tsuji; N Ikeda
Journal:  Int J Legal Med       Date:  2008-07-19       Impact factor: 2.686

Review 2.  Pilsicainide.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

3.  Different time courses of the blockade of sodium current by lignocaine and SUN 1165 in single myocytes isolated from guinea-pig atrium.

Authors:  N Inomata; T Ishihara; N Akaike
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

4.  [Efficacy and safety of a single oral dose of pilsicainide in supraventricular arrhythmia after coronary artery bypass grafting].

Authors:  K Kohno; Y Takeuchi; A Gomi; H Nakatani; Y Suda; T Shimabukuro; N Nagano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-04

5.  Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig.

Authors:  N Inomata; T Ishihara; N Akaike
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

6.  Pilsicainide Intoxication with Neuropsychiatric Symptoms Treated with Continuous Hemodiafiltration.

Authors:  Marina Asano; Takuto Hayakawa; Yuki Kato; Kyogo Kawada; Shuji Goto; Joel Branch; Hideaki Shimizu
Journal:  Intern Med       Date:  2020-05-26       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.